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Abstract 
Objective: Self-efficacy is a known predictor of patient-reported outcomes (PROs) in 
individuals with acquired diseases. With an overall objective of better understanding PROs in 
adults with congenital heart disease (CHD), this study aimed to: (i) assess self-efficacy in 
adults with CHD, (ii) explore potential demographic and medical correlates of self-efficacy, 
and (iii) determine whether self-efficacy explains additional variance in PROs above and 
beyond known predictors.  
Methods: As part of a large cross-sectional international multi-site study (APPROACH-IS), 
we enrolled 454 adults (median age 32 years, range: 18-81) with CHD in two tertiary care 
centers in Canada and Switzerland. Self-efficacy was measured using the General Self-
Efficacy (GSE) scale, which produces a total score ranging from 10 to 40. Variance in the 
following PROs was assessed: perceived health status, psychological functioning, health 
behaviors, and quality of life (QOL). Hierarchical multivariable linear regression analysis was 
performed.  
Results: Patients’ mean GSE score was 30.1 ± 3.3 (range: 10 - 40). Lower GSE was 
associated with female sex (p = 0.025), not having a job (p = 0.001), and poorer functional 
class (p = 0.048). GSE positively predicted health status and QOL, and negatively predicted 
symptoms of anxiety and depression, with an additional explained variance up to 13.6%. No 
associations between self-efficacy and health behaviors were found.  
Conclusions: GSE adds considerably to our understanding of PROs in adults with CHD. 
Given that self-efficacy is a modifiable psychosocial factor, it may be an important focus for 
interventions targeting CHD patients’ well-being.  
 
 
Keywords: Self Efficacy; Patient-Reported Outcomes; Heart Defects, Congenital;  
Multicenter Study 
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Introduction  
In developed countries, adults with congenital heart disease (CHD) now outnumber children 
with CHD.1 Despite significant medical and surgical improvements, CHD remains a life-long 
medical condition and long-term complications are common.2 Living with CHD often entails 
physical and psychosocial adaptations to the underlying defect and its treatment and also has 
lifestyle implications with respect to physical activity, employment, and family planning. Thus, 
optimizing patients’ overall well-being and quality of life (QOL) has emerged as an important 
goal when caring for adults with CHD.3 To achieve this aim, patient-reported outcomes (PROs) 
are increasingly valued in addition to traditional medical parameters.4 PROs are directly 
reported by patients, “without interpretation of the patient’s response by a clinician or anyone 
else”.5 PROs thus offer unique insight into how patients sense and judge their health and well-
being. 
A large international study investigating PROs in CHD was performed: Assessment of 
Patterns of Patient-Reported Outcomes in Adults with Congenital Heart disease - International 
Study (APPROACH-IS).6 APPROACH-IS demonstrated that PROs were independently and 
consistently predicted by functional status, age, and unemployment status.7 The impact of self-
efficacy as a potential explanatory factor above and beyond other known predictors is unknown. 
Self-efficacy refers to beliefs about one’s ability to perform desired tasks; individuals with 
higher self-efficacy “approach difficult tasks as challenges to be mastered rather than as threats 
to be avoided”. 8 
Self-efficacy has previously been linked with PROs. In patients with non-cardiac conditions 
(e.g., breast and gastro-intestinal cancer), low self-efficacy has been associated with increased 
symptom severity, more pain and decreased physical and emotional functioning.9 Following 
myocardial infarction, patients who rated the perceived consequence of the disease higher also 
reported low general self-efficacy.10 Among adolescents and adults with other chronic illnesses, 
such as diabetes or chronic heart failure, higher self-efficacy has been associated with better 
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QOL.11, 12 A recent published study also found higher transition readiness in adolescent CHD 
patients with greater self-efficacy.13 Self-efficacy has not yet been evaluated in adults with 
CHD, and it is unclear to what extent self-efficacy predicts PRO above and beyond known 
demographic and clinical correlates.  
Therefore, the aims of the current study were to 1) assess self-efficacy in adults with CHD, 
2) explore potential demographic and medical correlates of self-efficacy, and 3) investigate 
whether self-efficacy explains additional variance in PROs above and beyond known 
predictors. 
 
Methods 
The present study is a sub-study conducted within APPROACH-IS, which was a cross-sectional 
multicenter study of PROs in more than 4000 adults with CHD from 24 centers in 15 countries 
(ClinicalTrials.gov: NCT02150603).6, 14 For the current sub-study, two participating centers 
(Toronto, Canada and Bern, Switzerland) included an additional assessment of self-efficacy 
within their set of questionnaires. Approval for APPROACH-IS, including this sub-study, was 
obtained by the corresponding local ethic committees, according to the principles outlined in 
the Declaration of Helsinki.  
Study population and procedure 
Inclusion criteria were consistent with the APPROACH-IS protocol: (i) CHD diagnosed before 
the age of 10 years, (ii) at least 18 years old at the time of study participation, (iii) physical, 
cognitive and language skills to complete the study questionnaires, and iv) cardiology follow-
up at one of the two participating centers.6 Exclusion criteria were: (i) prior heart transplantation 
and (ii) primary pulmonary hypertension. Data collection took place between January and 
December 2014. At the Toronto center, patients were recruited during clinic visits; survey 
completion (in English) occurred in the clinic setting or at home (in which case patients were 
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given stamped, pre-addressed envelopes). At the Bern center, patients were mailed a 
questionnaire package with a consent form (available in either German or French) and a 
stamped self-addressed envelope prior to their scheduled follow-up appointment. Where no 
translation was already available, forward-backward procedures based on the MAPI method 15 
to ensure that cross-cultural, conceptual and linguistic equivalence was ensured.  
 
Measures 
Demographic and medical characteristics 
Study participants completed a demographic survey that included age, sex, marital and 
parenting status, education and employment status, and religiosity. Patients’ functional status 
was assessed with the NYHA functional class I-IV self-report questionnaire, in which class I 
indicates no limitations and class IV indicates severe limitations with symptoms even while at 
rest.6 Medical records were consulted to document defect complexity (categorized as mild, 
moderate or great),16 history of cardiac surgery, history of congestive heart failure, arrhythmias, 
implantation of a pacemaker or implantable cardioverter defibrillator, and documented mood 
or anxiety disorders. 
General self-efficacy 
Self-efficacy was measured with the 10-item General Self-Efficacy (GSE) scale.17, 18 An 
example of an item is “I am confident that I could deal efficiently with unexpected events.” 
Responses are provided on a four-point scale ranging from 1 (“not at all true”) to 4 (“exactly 
true”) and summed to a total score ranging from 10 to 40. A higher total score reflects a higher 
level of self-efficacy. This scale has been used in various settings with internal consistency 
coefficients ranging from 0.75 to 0.91.19 In the present study, the corresponding internal 
consistency coefficient was 0.90, indicating strong reliability.  
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Patient Reported Outcomes (PROs) 
Self-report questionnaires were used to assess four PRO domains: perceived health status, 
health behaviors, psychological functioning and QOL.6 Perceived health status was assessed 
with the EuroQOL-5D Visual Analog Scale 20 and the 12-item Short Form Health Survey. 21 
Scores on the latter instrument produce a physical component summary (PCS) as well as a 
mental component summary (MCS). Health enhancing and health compromising behaviors 
were measured with the Health-Behavior Scale-Congenital Heart Disease. 22 Psychological 
functioning was assessed using the Hospital Anxiety and Depression Scale 23, which produces 
an anxiety score (HADS-A) and depression score (HADS-D). Quality of life was appraised 
using the Linear Analog Scale (LAS-QOL) 24 and the Satisfaction with Life Scale (SWLS). 25 
Online Table 1 provides an expanded definition of the domains as applied in APPROACH-IS 
as well as the interpretation of scores, validity and reliability of the above mentioned 
measurements.  
Statistical analysis 
For categorical variables, absolute numbers and percentages are presented. Continuous 
variables are presented as means and standard deviations if normally distributed, or medians 
with range, if not normally distributed. To investigate whether GSE differed according to 
demographic and medical characteristics, unpaired t-tests or ANOVA and Mann-Whitney U-
test or Kruskal Wallis tests were computed as appropriate. To assess how PROs are affected by 
patients’ self-efficacy, we conducted hierarchical, multivariable linear regression analyses. We 
ran separate analyses using the following dependent variables: perceived health status (Physical 
Component Summary (PCS), Mental Component Summary (MCS) and the EuroQol 5 
Dimensions-Visual Analog Scale (EQ-VAS)), health behavior (CHD Health-Behavior scale), 
psychological functioning (Hospital Anxiety and Depression scale (HADS-A, HADS-D)) and 
QOL (LAS-QOL and SWLS). Using a hierarchical approach, in the first step we included 
demographic and clinical variables, namely, functional NYHA class, age and employment 
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status, because these variables have been identified previously as correlates of PROs within the 
APPROACH-IS dataset7. Further we included sex, marital status, educational level, center 
(Bern vs Toronto) and disease complexity. In the second step we included general self-efficacy, 
which allowed us to investigate a change in explained variance. In all analyses, the null 
hypothesis was rejected for p-values <0.05 and two-sided tests were used. Statistical analysis 
was performed using IBM SPSS Statistics 21 (Armonk, NY: IBM Corp.). 
 
Results 
Patient characteristics 
Of the 809 eligible patients approached by mail or in person, 454 (56%) agreed to participate 
and completed questionnaires. The majority of participants (80%) had CHD of moderate or 
great complexity. Most patients (58%) reported being in NYHA class I. A total of 365 (80%) 
patients had undergone cardiac repair in the past, half of them were operated in 2001 or later. 
Additional demographic and medical characteristics are summarized in table 1. 
[Insert Table 1] 
General self-efficacy scores and its correlates  
The mean GSE score was 30.1 ± 3.3 (range: 10 – 40). Univariate analysis showed that GSE 
scores were significantly lower among women (p=0.025), in patients who were unemployed, 
job seeking or on disability (p=0.001), or in NYHA Class III or IV (p=0.048) (Table 2). GSE 
scores did not differ as a function of age, marital status, children, educational background, or 
religiosity. There was also no association between GSE scores and the following medical 
characteristics: CHD complexity, history of congestive heart failure, history of arrhythmias, 
having a cardiac device or documented mood or anxiety disorders. When performing 
multivariable linear regression analysis, only gender and NYHA Class turned out to be 
significant correlates of GSE. 
[Insert Table 2] 
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The relationship between self-efficacy and PRO 
Multivariable linear regression analysis was conducted to assess whether general self-efficacy 
adds a significant portion of the explained variance of PROs. Results indicated that after 
adjusting for demographic and clinical factors, higher GSE significantly predicted better health 
status (PCS, MCS and EQ-VAS), less anxiety and depression (HADS-A and HADS-D), and 
better QOL (LAS QOL and SWLS). However, self-efficacy was not related to CHD-specific 
health behaviors. In Table 3, we separately present the R2 variance explained by the overall 
model (i.e., including variables from both steps) as well as the change in R2 variance after the 
second step in which GSE was entered. As shown in this table, the additional variance 
associated with the inclusion of GSE in the model was over 10% for MCS, HADS-D, and 
SWLS.  
[Insert Table 3]  
Discussion  
Although self-efficacy had been associated with QOL and other PROs in patients with other 
chronic conditions, its relevance for adults with CHD was previously unknown. Therefore, this 
study was undertaken to understand demographic and medical correlates of self-efficacy and 
investigate whether self-efficacy explains variance in PROs above and beyond known 
demographic and clinical predictors.  
General self-efficacy in adults with CHD  
The mean GSE score of adults with CHD in this study was 30.1, which is similar to the mean 
score of 29.5 that has been observed in the international general population.26 Schwarzer & 
Jerusalem, the authors of the GSE scale, do not recommend categorizing in high and low self-
efficacy. This suggests that, as a group, their self-efficacy is comparable to the general 
population. Perhaps this should not be surprising, given that most have mastered multiple 
health-related challenges throughout their lives.  
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Correlates of self-efficacy observed in the present study were consistent with findings of 
previous studies in diverse chronic patient populations.27-29 In our patient cohort, lower self-
efficacy was observed in patients who were female and not employed. We additionally found 
that lower self-efficacy was observed in patients with poorer functional status, but did not differ 
as a function of disease complexity. Although causality cannot be determined from a cross-
sectional study, providers should remain aware that self-efficacy is likely more affected by the 
symptoms and experiences of patients rather than the original CHD diagnosis.  
Self-efficacy as predictor of PROs 
We observed that self-efficacy contributed significantly to the explained variance of PROs 
beyond that attributable to demographic and clinical factors. Most notably, after including GSE 
scores, the explained variance increased when predicting depressive symptoms (13.6%), mental 
health status (10.7%), satisfaction with life (10.9%), QOL (9.2%), and anxiety symptoms 
(5.9%). Thus, self-efficacy is a factor that warrants significant attention as clinicians and 
researchers strive to better understand and enhance the lives of adults with CHD. It is interesting 
that self-efficacy added very little (0.9%) to the model predicting physical health status. 
However, this might be due to the fact that the explained variance in the overall model 
predicting physical health status was the highest of all PROs (almost 55%) after the first step, 
before self-efficacy was entered into the model.  
Surprisingly, we did not observe a relationship between self-efficacy and health behaviors. 
This was unexpected because numerous studies previously demonstrated that self-efficacy is 
associated with better health behaviors such as adhering with dietary or physical activity 
recommendations.30-32 Among children and adolescents with CHD, the belief in one’s self-
efficacy was shown to correlate with increased physical activity, independent of disease 
complexity.33, 34 This discrepancy with our results may be related to the fact that we used a 
general self-efficacy measure, instead of an exercise-related questionnaire as was administered 
in pediatric studies. As the GSE questionnaire was developed to measure a confidence in 
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managing general adverse situations, it may thus be less applicable to adherence with specific 
health behaviors.  
Our results regarding the links between self-efficacy with mental health status, anxiety and 
depression are consistent with observations in healthy samples as well as patients with chronic 
disease. 35, 36, 37 A meta-analysis of 181 studies among cancer patients demonstrated large effect 
sizes for (i) the positive relationship between QOL and self-efficacy for coping with cancer, 
and (ii) the inverse relationship between distress and self-efficacy for coping with cancer. 38 It 
should be acknowledged, however, that the directionality of the relationships between self-
efficacy and PROs remains unknown from our study. It is plausible that higher self-efficacy 
throughout the life of an adult with CHD leads to a sense of general accomplishment and thus 
overall well-being. 8  It is equally plausible that better psychological health leads one to be more 
optimistic that their attempts to master tasks (both related and unrelated to health) will be 
successful.  
In summary, the recognition of the significant relationship between general self-efficacy and 
PROs holds important implications for interventions targeting mental health of adults with 
CHD. For example, a multidisciplinary self-management course based on Bandura’s self-
efficacy concept has shown to be effective in increasing self-efficacy for individuals with 
chronic conditions,39 including arthritis, diabetes and heart diseases. The program included 
strategies on decision making, problem solving skills and social persuasion through group 
sessions. Participants not only showed better self-efficacy and health status (pain, depression, 
fatigue) after one year, but also better communication with health care providers and fewer 
visits to the emergency department. This example is consistent with other studies on self-
management programs based on Bandura’s self-efficacy concept. 40  
General clinical recommendations for nurses and other healthcare professionals involved in 
the care of adults with CHD can therefore be adapted from existing self-management 
guidelines: establishing a reliable and collaborative relationship, engaging in goal-setting to 
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help patients achieve their goals (both related and unrelated to health), and asking patients about 
their confidence in making changes.41 During regular clinical encounters in the inpatient or 
outpatient setting, nurses can focus on enabling patients by fully engaging them in decision-
making and highlighting patient achievements. Examples warranting positive verbal 
reinforcement include attending clinic appointments despite logistical challenges, educating 
themselves about their diagnoses, and effectively explaining symptoms to providers. Some 
patients may also benefit from peer support groups. 42 
Methodological considerations 
A strength of this study is that it was undertaken within a large international study with a sound 
research methodology based on established conceptual foundations. Further, by including 
patient cohorts from two centers in Canada and Switzerland, we avoided single-center bias and 
are thus more confident in our ability to explore the relationship between general self-efficacy 
and PROs. However, there are also methodological limitations to be considered when 
interpreting the data. The first pertains to the generalizability of study findings. We cannot 
conclude that our data are applicable to adults with CHD who are not followed in a major center 
or who are followed at our centers but chose not to take part in our study. The same refers to 
different ethnic groups, since the majority of our study population was Caucasian/white.  
Second, the cross-sectional design does not allow us to determine directionality of the 
relationships between self-efficacy and PROs. To investigate this, longitudinal data or an 
intervention targeting a change in self-efficacy would be required. Cross-lagged analyses on 
longitudinal data would allow us to determine if self-efficacy is influencing PROs, or vice versa. 
Furthermore, future studies on self-efficacy enhancing interventions are important to learn 
whether increasing self-efficacy yields improvements of PROs. Third, we did not measure 
disease-specific or behavior-specific self-efficacy, which might have contributed to the absence 
of a relationship between self-efficacy and health behaviors. Fourth, history of heart-failure  and 
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arrhythmias as well as documentation of anxiety and depression was abstracted from the 
medical record and objective verification was not possible.  
Finally, although statistically significant relationships between general self-efficacy with sex, 
employment status, and functional class were observed, the absolute differences were small. It 
would be important to define the minimal clinically important difference for the GSE scale in 
order to determine whether these differences are clinically meaningful. 
 
 
 
Conclusions 
Higher self-efficacy was associated with more desirable scores in several PRO domains, 
notably mental health status, symptoms of depression, and QOL. Given that self-efficacy is a 
modifiable psychosocial variable, this holds important potential as a target for clinical 
intervention, both in regular clinical encounters as well as within the context of mental health 
intervention.  
 
Implications for Practice 
 The patients’ confidence in their ability to manage life challenges, was associated with 
several positive outcomes, particularly mental health and QOL. 
 Cardiovascular nurses can play an important role in the assessment of general self-
efficacy in patients with CHD.  
 Promoting self-management strategies may help to enhance patients’ general self-
efficacy.  
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Figures and Tables 
Table 1. Demographic and medical characteristics 
 Participants N = 454 
 
Median age in years (range)  
Age in groups, n (%) 
18-25 
26-30 
31-35 
36-40 
41-45 
>45 
 
32.0 (18-81) 
 
141 (31.1) 
71 (15.6) 
62 (13.7) 
41 (7.0) 
32 (7.0 
107 (23.6) 
Center, n (%) 
Toronto 
Bern 
 
 
176 (38.8) 
278 (61.2) 
Male sex, n (%), 
 
248 (54.6) 
 
Background (N = 445), n (%) 
White/Caucasian 
Asian 
Hispanic/Latino 
Middle-Eastern/Arabic 
Black/African-American 
Other 
 
 
372 (83.6) 
32 (7.2) 
18 (4.0) 
15 (3.4) 
7 (1.6) 
1 (0.2) 
Marital Status (N = 450), n (%) 
Never married/unmarried 
Married or living with a partner 
Divorced or widowed 
Other 
 
 
219 (48.7) 
207 (46.0) 
23 (5.1) 
1 (0.2) 
Has at least one child (N = 448), n (%) 
 
154 (34.4) 
 
Employment (N = 449), n (%) 
Full-time/Part-time  
Job seeking, unemployed or disability 
Homemaker or retired 
Other 
 
 
329(73.3) 
64 (14.2) 
28 (6.2) 
28 (6.2) 
Education (N = 446), n (%) 
High school 
College degree 
University degree  
Less than high school 
 
 
206 (46.2)  
117 (26.2) 
107 (24.0) 
16 (3.6) 
Consider self as religious or spiritual (N = 444), n (%) 
 
152 (34.2) 
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Complexity of the heart defect, n (%) 
Mild 
Moderate 
Great 
 
 
91 (20.0) 
221 (48.7) 
142 (31.3) 
History of cardiac surgery, n (%) 
 
365 (80.4) 
Congestive heart failure, n (%) 
Never 
Past, not current 
Current 
 
 
422 (93.0) 
19 (4.2) 
13 (2.9) 
 
Patient-reported functional class (N = 445), n (%) 
NYHA I 
NYHA II 
NYHA III 
NYHA IV 
 
 
264 (59.3) 
137 (30.8) 
37 (8.3) 
7 (1.6) 
Any history of arrhythmia, n (%) 
 
134 (29.5) 
 
Cardiac device (N = 453), n (%) 
None 
Pacemaker  
Implantable Cardioverter Defibrillator  
 
 
409 (90.3) 
35 (7.7) 
9 (2.0) 
Any history of mood disorder (N = 453), n (%) 
 
27 (6.0) 
Any history of anxiety disorder, n (%) 
 
19 (4.2) 
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Table 2. General Self-Efficacy as a function of univariate demographic and medical 
predictors 
              Mean GSE  
(± Standard Deviation) 
t/F-Value p 
Sex 
Male 
Female 
 
 
30.6 (±4.9) 
29.5 (±5.4) 
2.250 0.025 
Marital Status 
Never married 
Married or living with a partner 
Divorced or widowed 
Other 
 
 
29.5 (±5.2) 
30.7 (±5.0) 
31.2 (±5.0) 
34.0 (±5.2) 
2.292 0.077 
Children 
Yes 
No 
 
29.9 (±5.1) 
30.6 (±5.2) 
-1.499 0.135 
Education 
Less than high school 
High school 
College degree 
University degree 
 
 
30.6 (±2.7) 
30.1 (±5.4) 
29.6 (±5.4) 
30.4 (±4.7) 
0.503 0.680 
Work 
Full-time/Part-time 
Homemaker or retired 
Job seeking, unemployed or disability 
Other 
 
 
30.1 (±5.1) 
31.5 (±3.8) 
28.5 (±5.7) 
32.8 (±4.9) 
5.249 0.001 
Religiosity 
Yes, I consider myself religious or spiritual 
No 
 
 
30.8 (±4.8) 
29.8 (±5.3) 
-1.935 0.054 
Patient-reported functional class 
NYHA I 
NYHA II 
NYHA III 
NYHA IV 
 
 
30.6 (±4.8) 
29.6 (±5.6)  
28.4 (±5.1) 
29.0 (±2.5) 
2.653 0.048 
Complexity of the heart defect 
Simple 
Moderate 
Great 
 
 
31.1 (±5.1) 
30.1 (±4.7) 
29.5 (±5.7) 
2.629 0.073 
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Congestive Heart-failure 
Never 
Past, not current 
Current 
 
 
30.1 (±5.2) 
30.2 (±4.6) 
29.7 (±6.3) 
0.047 0.954 
History of arrhythmia 
Yes 
No 
 
29.8 (±5.0) 
30.2 (±5.2) 
 
0.704 0.482 
Cardiac device 
None 
Implantable Cardioverter Defibrillator 
Pacemaker 
 
 
30.2 (±5.2) 
32.4 (±5.9) 
28.7 (±4.6) 
2.191 0.113 
Mood disorder 
Yes 
No 
 
 
28.6 (±6.1) 
30.2 (±5.1) 
1.564 0.119 
Anxiety disorder 
Yes 
No 
 
 
28.4 (±5.5) 
30.2 (±5.1) 
1.505 0.133 
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Table 3. Multivariable linear regression analysis with GSE as predictor of PROs, adjusted for patient characteristics (n=386) 
 
P
C
S
 
M
C
S
 
E
Q
-V
A
S
 
H
A
D
S
-A
 
H
A
D
S
-D
 
H
ea
lt
h
 b
eh
av
io
r 
L
A
S
 Q
O
L
 
S
W
L
S
 
B (Standard error) 0.4 (0.1-0.6)* 1.2 (0.8-1.4)*** 0.8 (0.6-1.0) *** -0.2 (-0.2- -0.1) *** -0.2 (-0.3- -0.2) *** -0.03 (-0.3- 0.3) 1.0 (0.8-1.3) *** 0.5 (0.4-0.6) *** 
R² overall model 55.7% 36.9% 52.0% 30.0% 44.8% 11.4% 49.4% 46.3% 
R² change for general self-efficacy/ 0.9% 10.7% 5.9% 5.9% 13.6% 0.0% 9.2% 10.9% 
*=p<0.05, **=p<0.01, ***=p<0.001 
 
 
# = reference category; Values in table are Estimates (95% Confidence Intervals); Color coding refers to significance of estimate; PCS=Physical 
Component Summary; MCS=Mental Component Summary; EQ-VAS=EuroQol 5 Dimensions-Visual Analog Scale; HADS-A=Hospital Anxiety 
and Depression Scale – Anxiety; HADS-D= Hospital Anxiety and Depression Scale – Depression; LAS QOL= Linear Analog Scale Quality of Life; 
SWLS=Satisfaction with Life Scale  
 
 
 
 
 
